FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377475005: Product containing precisely hydrochlorothiazide 50 milligram and methyldopa 500 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3501720018 Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3679595012 Product containing precisely hydrochlorothiazide 50 milligram and methyldopa 500 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1202794010 Hydrochlorothiazide + methyldopa 50mg/500mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1215647011 Hydrochlorothiazide + methyldopa 50mg/500mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1215647011 Hydrochlorothiazide + methyldopa 50mg/500mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1478832016 Hydrochlorothiazide+methyldopa 50mg/500mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3486133010 Product containing hydrochlorothiazide 50 mg and methyldopa 500 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3491881016 Product containing hydrochlorothiazide 50 mg and methyldopa 500 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3501720018 Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3569393018 Product containing only hydrochlorothiazide 50 mg and methyldopa 500 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3569394012 Product containing only hydrochlorothiazide 50 mg and methyldopa 500 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3679595012 Product containing precisely hydrochlorothiazide 50 milligram and methyldopa 500 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3679596013 Product containing precisely hydrochlorothiazide 50 milligram and methyldopa 500 milligram/1 each conventional release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Is a Methyldopa-containing product false Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Is a Methyldopa+diuretic false Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Methyldopa (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Is a Product containing hydrochlorothiazide and methyldopa (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Hydrochlorothiazide (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has manufactured dose form Conventional release oral tablet (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Is a Product manufactured as oral dose form (product) false Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Centrally acting hypotensive agent false Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Is a Hydrochlorothiazide-containing product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Is a Methyldopa-containing product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Hydrochlorothiazide (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has basis of strength substance (attribute) Hydrochlorothiazide (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has presentation strength numerator value 50 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Methyldopa (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has basis of strength substance (attribute) Methyldopa (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has presentation strength numerator value 500 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has basis of strength substance (attribute) Methyldopa (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has presentation strength numerator value 500 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has basis of strength substance (attribute) Hydrochlorothiazide (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has presentation strength numerator value 50 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has precise active ingredient Methyldopa (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has precise active ingredient Hydrochlorothiazide (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Count of base of active ingredient deux false Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Is a Hydrochlorothiazide and methyldopa only product in oral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Plays role Diuretic therapeutic role false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start